
FDA releases new study findings for ESA use in cancer patients.
Medication therapy management opportunities expand in Ohio.
Major drugstore chains report weak December sales.
NACDS Foundation increases pharmacy student scholarships.
Florida and Wyoming officials explore real-time monitoring of prescription medications.
Drug Topics' poll finds pharmacists against Mevacor going OTC.
Prescription drug samples rarely go to poor and uninsured according to Harvard study.
Florida and Wyoming officials explore real-time monitoring of prescription medications.
Ferring fertility program expanded
New rule requires pharmacies to provide patients with a toll-free number to report adverse events.
Pharmacist donates $2 million to Massachusetts College of Pharmacy and Health Sciences
FDA issues warning on supplements marketed for ED, sexual enhancement
A judge has ruled that a Maine law barring prescribing information from being used for marketing is unconstitutional
New ADA recommendations state weight-loss plans are equally effective
The lack of accountability in controlled substance recordkeeping has prompted the Drug Enforcement Administration to revoke a Medicine Shoppe pharmacy's registration as of Feb 1.
Voluven is approved for blood loss
NACDS offers Web access to two studies on improving front-end sales
Legislation introduced to restrict access to DHEA
PPA helps needy Americans fill their prescriptions this holiday season
Group to help retailers meet IRS requirements for IIAS transactions
Interim recommendations issued for Hib vaccine shortage
The DEA has suspended the license from a third Cardinal Health distribution center located in Swedesboro, N.J.
FDA approves new indication for Thyrogen
Ranolazine label has been updated to reflect the drug's mechanism of action
Medco is erecting a new mail-order pharmacy in Indiana, which it claims will be the world's largest
AHRQ report examines use of osteoporosis drugs
Survey reveals nurses frustrated by computer systems.
The Office of Inspector General finds that many Medicare prescription drug plans fail to fully track beneficiaries' out-of-pocket spending.
Revised USP Chapter (797) available online free for limited time